Search results for “Cerebrovascular Ischemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 82 patents, we discovered top 35 key players by total patent application. St. Elizabeth's Medical Center, Ipsen Pharma SAS, Warner-Lambert Co. are dominant in this area. They take 26.83% of the total patent filing.
St. Elizabeth's Medical Center
Massachusetts, United States
Patent: 9
Ipsen Pharma SAS
France
Patent: 7
Warner-Lambert Co.
New Jersey, United States
Patent: 6
Neurondawn Pharmaceutical Co., Ltd.
China
Patent: 6
Syntex Pharmaceuticals Ltd.
Ireland
Patent: 5
Pfizer Inc.
New York, United States
Patent: 3
Taisho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
RaQualia Pharma, Inc.
Aichi-ken, Japan
Patent: 2
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 2
Tekelec Corp.
United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 29 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Neurondawn Pharmaceutical Co., Ltd., Seoul University Industry Academic Cooperation Foundation, Anhui University of Chinese Medicine take 48.28% of patent filing during this period.
Neurondawn Pharmaceutical Co., Ltd.
China
Patent: 6
Seoul University Industry Academic Cooperation Foundation
South Korea
Patent: 6
Anhui University of Chinese Medicine
Anhui Sheng, China
Patent: 2
Yantai Yene Pharma Co Ltd
Shandong Sheng, China
Patent: 1
Shanghai Cui Microbial Pharmaceutical Technology Co., Ltd.
Shanghai Shi, China
Patent: 1
Heilongjiang Rutai Technology Development Co., Ltd.
Heilongjiang Sheng, China
Patent: 1
Famenity Co Ltd
United States
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
L'Air Liquide SA
France
Patent: 1
Hefei Industrial Pharmaceutical Co Ltd
Anhui Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 29 patents in last 5 years, we discover 14 new entrants. Neurondawn Pharmaceutical Co., Ltd., Seoul University Industry Academic Cooperation Foundation, Yantai Yene Pharma Co Ltd are the most active new entrants in this area.
Neurondawn Pharmaceutical Co., Ltd.
China
Patent: 6
Seoul University Industry Academic Cooperation Foundation
South Korea
Patent: 6
Yantai Yene Pharma Co Ltd
Shandong Sheng, China
Patent: 1
Shanghai Cui Microbial Pharmaceutical Technology Co., Ltd.
Shanghai Shi, China
Patent: 1
Heilongjiang Rutai Technology Development Co., Ltd.
Heilongjiang Sheng, China
Patent: 1
Famenity Co Ltd
United States
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
L'Air Liquide SA
France
Patent: 1
Hefei Industrial Pharmaceutical Co Ltd
Anhui Sheng, China
Patent: 1
Hefei Enruite Pharmaceutical Co Ltd
Anhui Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 6 universities and scientific research institutions by total patent application. Anhui University of Chinese Medicine, Third Military Medical University, Peking University are dominant in this area. They take 52.38% of the total patent filing.
Anhui University of Chinese Medicine
Anhui Sheng, China
Patent: 3
Third Military Medical University
Chongqing Shi, China
Patent: 2
Peking University
Beijing Shi, China
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
China Medical University (Taiwan)
Taiwan Province, China
Patent: 1
Université de Caen Basse-Normandie
New Mexico, France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: